Stefoni S, Feliciangeli G, Coli L, Scolari M P, Bonomini V
Int J Artif Organs. 1981 Jul;4(4):186-91.
Charcoal hemoperfusion has long been used in chronic uremia as an adjunct or substitute for conventional hemodialysis. In this study a regular combination of hemoperfusion and hemodialysis was used to cut down the weekly substitutive sessions from 3 to 2. Ten RDT patients were treated with the reduced-time schedule for 5-56 weeks. Clinical and metabolic conditions remained stable in all patients and no sign of inadequate treatment appeared. Long-term charcoal hemoperfusion was confirmed to be a safe and risk-free procedure. No change in platelets, white cells, red cells, fibrinogen and other hematochemical parameters were detected.
长期以来，活性炭血液灌流一直被用于慢性尿毒症，作为传统血液透析的辅助手段或替代方法。在本研究中，采用血液灌流与血液透析的常规联合方法，将每周的替代治疗次数从3次减少到2次。10例接受规律透析治疗（RDT）的患者按减少后的治疗时间方案治疗了5至56周。所有患者的临床和代谢状况保持稳定，未出现治疗不足的迹象。长期活性炭血液灌流被证实是一种安全无风险的治疗方法。未检测到血小板、白细胞、红细胞、纤维蛋白原及其他血液化学参数的变化。
